infection and vaccination status of children aged 6 months-12 years: Time for mass vaccination

Iranian Journal of Pediatrics

Volumn 23, Issue 3, 2013, Pages 276-280

  Nalbantoglu, Burcin ^a   Donma, Metin M ^a   Ozdilek, Burcu ^a   Karasu, Erkut ^a   Nalbantoglu, Aysin ^b  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

^b Muratli State Hospital   (Turkey)

Author keywords

Hepatitis; Hepatitis A Virus; Immunization; Vaccination

Indexed keywords

HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS A; HUMAN; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; ONSET AGE; PRESCHOOL CHILD; RESIDENTIAL AREA; SCHOOL CHILD; SEROPREVALENCE; TURKEY (REPUBLIC);

EID: 84878666860     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004;38(5);705-15.
2. Mathur P, Arora NK. Epidemiological transmission of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008;128(6): 699-704.
3. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001;14(1):38-58.
4. Barzaga BN. Hepatitis A shifting epidemiology in South-east Asia and China. Vaccine 2000; 18(Suppl 1):S61-4.
5. Beyazova U. Is the individual a vaccination for our country's children correct? In: Programme and Congress Book of V. National Symposium on Viral Hepatitis; 2000 Nov 9-11, Ankara, Turkey, Ankara: Viral Hepatitle Savasim Dernegi, 2000; pp 20-34. [In Turkish]
6. Prime Ministry State Planning Organization. T.C. Basbakanlik Devlet Planlama Teskilati Müstesarligi. Available at: http://www.dpt.gov.tr/bgyu/seg/ iller2003.html. Access date: Jan 13, 2006. [In Turkish]
7. Prime Ministry Republic of Turkey Turkish Statistical Institute; T. C Basbakanlik Türkiye Istatistik Kurumu Ankara 2009 Available at: http://www.turksatgov.tr/Pretablo.do?tb_id=24&u st_id=7. Access date: May 30, 2009. (In Turkish)
8. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10(Suppl 1):S56-8.
9. Ceran N, Kocdogan FY, Mert D, et al. Hepatitis A seroprevalance in children and young adults in Istanbul, Turkey: seroprevalance change and associated factors. J Viral Hepat 2012; 19(1):72-6.
10. Erdogan MS, Otkun M, Otkun MT, et al. The epidemiology of hepatitis A virus infection in children, in Edirne, Turkey. Eur J Epidemiol 2004; 19(3):267-73.
11. Atabek ME, Findik D, Gülyüz A, et al. Prevalance of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004;67(3):265-9.
12. Sac RU, Bostanci I, Dallar Y, et al. Hepatitis A seroprevalance and demographics in Turkish children in Ankara. Pediatr Int 2009; 51(1):5-8.
13. Kurugol Z, Aslan A, Turkoglu E, et al. Changing epidemiology of hepatitis A infection in Izmir, Turkey. Vaccine 2011;29(37):6259-61.
14. Ceyhan M, Yildirim I, Kurt N, et al. Differences in hepatitis A seroprevalance among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008;15(Suppl 2): 69-72.
15. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalance: a global review and analysis. Epidemiol Infect 2004;132(6):1005-22.
16. Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev 2006;28:101-11.
17. Kang JH, Lee KY, Kim CH, et al. Changing hepatitis A epidemiology and the need for vaccination in Korea. Asian Pac J Allergy Immunol 2004;22(4):237-42.
18. Siegl G. Hepatitis A virus infection. A review. Praxis (Bern 1994) 2003;92(40):1659-73.
19. De Silva KS, Weerasuriya DC, Peelawattage M, et al. Seroprevalance of hepatitis A antibodies in relation to social factors-a preliminary study. Ceylon Med J 2005;50(2):54-8.
20. Halicioglu O, Akman SA, Tatar B, et al. Hepatitis A seroprevalance in children and adolescents aged 1¬18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis 2012;10(1):43-47.
21. FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine 2010;28(3):583-8.
22. Wasley A, Samandari T, Bell BP.' Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005;294(2):194-201.
23. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271(17):1328-34.
24. WHO. Hepatitis A vaccines position paper. Wkly Epidemiol Rec 2000;75(5):38-44.